Effects of sitagliptin on gastric emptying of, and the glycaemic and blood pressure responses to, a carbohydrate meal in type 2 diabetes. 2020

Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia.

To determine the effects of the dipeptidyl peptidase-4 inhibitor, sitagliptin, on gastric emptying (GE) of a high-carbohydrate meal and associated glycaemic and blood pressure (BP) responses in type 2 diabetes mellitus (T2DM). Fourteen patients with T2DM (nine men, five women; age 67.8 ± 1.5 years; body mass index 31.2 ± 0.9 kg/m2 ; T2DM duration: 4.2 ± 0.9 years; glycated haemoglobin: 46 ± 1.8 mmol/mol [6.4% ± 0.2%]), managed by diet and/or metformin, underwent concurrent measurements of GE, BP and plasma glucose for 240 minutes after ingestion of a radiolabelled mashed potato meal after receiving sitagliptin (100 mg) or placebo in randomized, double-blind, crossover fashion on 2 consecutive days. Sitagliptin reduced postprandial plasma glucose (P < .005) without affecting GE (P = .88). The magnitude of the glucose-lowering effect (change in incremental area under the curve0-240 min from placebo to sitagliptin) was related to GE (kcal/min) on placebo (r = 0.68, P = .008) There was a comparable fall in systolic BP (P = .80) following the meal, with no difference between the 2 days. In T2DM, while sitagliptin has no effect on either GE or postprandial BP, its ability to lower postprandial glucose are dependent on the basal rate of GE.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D004040 Dietary Carbohydrates Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277) Carbohydrates, Dietary,Carbohydrate, Dietary,Dietary Carbohydrate
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005746 Gastric Emptying The evacuation of food from the stomach into the duodenum. Emptying, Gastric,Emptyings, Gastric,Gastric Emptyings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
December 2004, Diabetologia,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
June 2006, The Journal of clinical endocrinology and metabolism,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
September 2009, Diabetes care,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
August 2015, Diabetologia,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
September 2008, Diabetic medicine : a journal of the British Diabetic Association,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
May 2019, Diabetes, obesity & metabolism,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
December 1998, Diabetic medicine : a journal of the British Diabetic Association,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
January 2021, Diabetes research and clinical practice,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
November 2003, QJM : monthly journal of the Association of Physicians,
Julie E Stevens, and Madeline Buttfield, and Tongzhi Wu, and Seva Hatzinikolas, and Hung Pham, and Kylie Lange, and Christopher K Rayner, and Michael Horowitz, and Karen L Jones
June 2015, International journal of clinical practice,
Copied contents to your clipboard!